ConductScience.org, home

Paper32089355

Pregnancy success rate and response to heparins and/or aspirin differ in women with antiphospholipid antibodies according to their Global AntiphosPholipid Syndrome Score.

Radin M and 6 others. Semin Arthritis Rheum, 2020. Cited by 16 papers, by iCite.

Cite this record

ConductScience Library. Pregnancy success rate and response to heparins and/or aspirin differ in women with antiphospholipid antibodies according to their Global AntiphosPholipid Syndrome Score. Papers, record 32089355. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32089355

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Pregnancy success rate and response to heparins and/or aspirin differ in women with antiphospholipid antibodies according to their Global AntiphosPholipid Syndrome Score.
PubMed
Journal
Semin Arthritis Rheum
PubMed
Year
2020
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
16
iCite
Relative citation ratio, by iCite
1.02
iCite
Revised in PubMed
2021-04-27
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Radin MM
2Cecchi II
3Schreiber KK
4Rubini EE
5Roccatello DD
6Cuadrado MJM J
7Sciascia SS

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antibodies, AntiphospholipidMajor topic
Antiphospholipid SyndromeMajor topic
AspirinMajor topic
Fibrinolytic AgentsMajor topic
Heparin, Low-Molecular-WeightMajor topic
Adult
Female
Humans
Live Birth
Pregnancy
Pregnancy Complications
Retrospective Studies

Source PubMed

Download CSV of topics

Cited by13

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 16 citations.

PMIDTitleJournalYearIn PapersSource
42564357Catastrophic Outcome of Pregnancy Complicated With Tricuspid Valve Nonbacterial Thrombotic Endocarditis.J Med Cases2026https://conductscience.org/library/papers/42564357PubMed
42063459Immune microenvironment dynamics in pregnant patients with concomitant autoimmune diseases: mechanisms, challenges, and clinical significance.Mil Med Res2026https://conductscience.org/library/papers/42063459PubMed
41890553Antiphospholipid syndrome and pregnancy-a hematologic perspective.Res Pract Thromb Haemost2026https://conductscience.org/library/papers/41890553PubMed
41596115Dietary Supplements in Pregnancy and Postpartum: Evidence, Safety Challenges and a Precision Nutrition Framework (GAPSS).Antioxidants (Basel)2026https://conductscience.org/library/papers/41596115PubMed
39768785Pregnancy Outcomes in Non-Criteria Obstetric Antiphospholipid Syndrome: Analysis of a Cohort of 91 Patients.J Clin Med2024https://conductscience.org/library/papers/39768785PubMed
39473986Studying Pregnancy Outcome Risk in Patients with Systemic Lupus Erythematosus Based on Cluster Analysis.Biomed Res Int2023https://conductscience.org/library/papers/39473986PubMed
39294500The 2023 ACR/EULAR antiphospholipid syndrome classification criteria identify patients at high risk of complications.Clin Rheumatol2024https://conductscience.org/library/papers/39294500PubMed
38948301[Obstetric Antiphospholipid Syndrome: Insights on the Diagnosis, Treatment, and Hot Issues].Sichuan Da Xue Xue Bao Yi Xue Ban2024https://conductscience.org/library/papers/38948301PubMed
37996129Development and external validation of a prediction model for venous thromboembolism in systemic lupus erythematosus.RMD Open2023https://conductscience.org/library/papers/37996129PubMed
37957714
Exosomal miR-146a-5p derived from human umbilical cord mesenchymal stem cells can alleviate antiphospholipid antibody-induced trophoblast injury and placental dysfunction by regulating the TRAF6/NF-κB axis.
J Nanobiotechnology2023https://conductscience.org/library/papers/37957714PubMed
36233742A Rare Case of Tricuspid Valve Libman-Sacks Endocarditis in a Pregnant Woman with Primary Antiphospholipid Syndrome.J Clin Med2022https://conductscience.org/library/papers/36233742PubMed
35547735Malignant Isolated Cortical Vein Thrombosis as the Initial Manifestation of Primary Antiphospholipid Syndrome: Lessons on Diagnosis and Management From a Case Report.Front Immunol2022https://conductscience.org/library/papers/35547735PubMed
34390384Biochemical and clinical predictors in pregnant women with antiphospholipid syndrome and systemic lupus erythematosus: comprehensive update.Arch Gynecol Obstet2021https://conductscience.org/library/papers/34390384PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/32089355

GET https://conductscience.org/api/papers/v1/32089355/authors